Skip to main content
BCYC logo

BCYC · Bicycle Therapeutics PLC · Earnings Call Transcripts & Audio

Track BCYC — free
$3.89 +0.03 (+0.66%)
Market Cap
$269.47M
Shares
69.99M

Bicycle Therapeutics PLC Earnings Call Transcripts

Quarterly earnings calls for Bicycle Therapeutics PLC (BCYC), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Earnings call
FY25 · Q3
2025-10-30
Bicycle Therapeutics PLC (BCYC) Q3 2025 Earnings Call
Revenue
$11.73M
▲ 338.5% YoY
Diluted EPS
$-0.85
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-08
Bicycle Therapeutics PLC (BCYC) Q2 2025 Earnings Call
Revenue
$2.92M
▼ 68.8% YoY
Diluted EPS
$-1.14
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Bicycle Therapeutics PLC (BCYC) Q1 2025 Earnings Call
Revenue
$9.98M
▼ 48.9% YoY
Diluted EPS
$-0.88
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Bicycle Therapeutics PLC (BCYC) Q4 2024 Earnings Call
Revenue
$3.71M*
▼ 30.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q1
2024-05-02
Bicycle Therapeutics PLC (BCYC) Q1 2024 Earnings Call
Revenue
$19.53M
▲ 298.9% YoY
Diluted EPS
$-0.62
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q3
2023-11-02
Bicycle Therapeutics PLC (BCYC) Q3 2023 Earnings Call
Revenue
$5.35M
▲ 76.1% YoY
Diluted EPS
$-1.26
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q3
2020-11-05
Bicycle Therapeutics PLC (BCYC) Q3 2020 Earnings Call
Revenue
$3.84M
▲ 525.7% YoY
Diluted EPS
$-0.52
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Bicycle Therapeutics PLC (BCYC) Q1 2020 Earnings Call
Revenue
$1.13M
▼ 82.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–8 of 8 earnings calls
Key facts CIK 1761612 CUSIP 088786108 13F (30d) 4 filings 4 filers Visit website Investor relations